Jack Moorman is a Partner in Nichibei MedTech Advisors and the Principal at LeVaunt, LLC.  Both are consulting firms providing advisory services to companies and organizations, particularly early stage ventures in the fields of healthcare and wellness consumer products. He was also recently honored to be named Visiting Faculty Member, Graduate School of Medicine, Osaka University.

Jack is also Chairman of US-Japan Medtech Frontiers, a nonprofit organization.  US-Japan Medtech Frontiers organizes conferences and symposia in Japan to promote collaboration between the US and Japan to create and commercialize novel medical devices.  Now in its Fourth year, USJMF has organized conferences in Sendai, Osaka, Hiroshima, and in 2017 the conference will be in Okinawa.  In addition, each year USJMF has organized a symposium for Japanese senior executives held in Tokyo with the support of the US Embassy.  USJMF is also a strong supporter of the Japan Biodesign Program, now in its second year.
 

With an undergraduate degree in Engineering from the University of Illinois, Jack initially worked in the semiconductor industry leading groups in packaging, testing, assembly, and military products. Jack was the first employee sponsored by Intel to attend the prestigious Stanford Business School Sloan Program where he received an MS in Management. On returning to Intel after the program, he transferred into the semiconductor equipment side of the business and after assignments in manufacturing, field service and marketing moved to Fairchild Test Systems where he became Director of Engineering. After Fairchild he spent five years as founder and director at GenRad Semiconductor Test, Inc. Subsequently Jack was hired by Nanometrics, Inc., public company, where he was promoted to President. Following Nanometrics, Jack did company turn-arounds in semiconductor equipment, medical devices, and in LCD manufacturing equipment. In 1992 Jack founded Cardiac Mariners where he was co-inventor of the technology for a novel x-ray system. In 1999, he founded MCT Medical which was merged with Vivant Medical and where he was CEO and co-inventor of their microwave ablation technology. Vivant was later sold to Tyco.

Jack has been involved in a wide array of companies, technology, and products. In addition to a turn-around in a semiconductor equipment company and Board membership at one of the largest U.S. providers of skilled nursing and assisted living, he has consulted with a Russian investment group on fiber lasers, a Chinese company supplying polyurethane materials, a ski equipment company, a company supplying consumer products to big box stores, Japanese companies looking for medical device acquisitions, consulted with two orthopedics robotic companies, developed a novel device for sentinel lymph node biopsy, and has been assisting Japanese companies in developing innovative medical devices.  To date, he has fourteen issued U.S. patents.